Enhanced therapeutic potential of AEBP1 silencing via engineered apoptotic mesenchymal stem cell-derived nanovesicles in atrial fibrillation
30 August 2025 (13:15 - 14:00)
Organised by: 

About the speaker

Seoul (Korea (Republic of))
7 More presentations in this session

Sequencing in over 120,000 cases unveils the rare coding variant architecture of atrial fibrillation
Mr S. Jurgens (Amsterdam, NL)

Doctor S. Van Laer (Edegem, BE)

Professor E. Cerbai (Florence, IT)

Associate Professor F. Wu (Beijing, CN)

Doctor V. Halatiu (Targu Mures, RO)
Access the full session
The Event
ESC Congress 2025
30 August 2025
13:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Presentation
29 August 2025



